PRIVEQ G.P. IV LIMITED

Thesis

PRIVEQ G.P. IV LIMITED is a private equity firm founded in 1983, which became independent in 1998. The firm focuses on investing in unlisted growth companies, aiming to enhance their value through capital and expertise. Their investment strategy involves providing tailor-made equity solutions to profitable, growing companies that require capital for expansion, buy-outs, or buy-ins. They also consider investments in profitable companies facing financial challenges, excluding operational turnarounds. Priveq targets niche service, distribution, and manufacturing companies, with past interests in Information & Communication Technology, Life Sciences & Pharma, and Banking & Insurance, and more recent investments in Healthcare and Retail. They typically invest in companies with minimum revenues of approximately $10 million USD and minimum operating profits of approximately $1 million USD, indicating a preference for established, growing businesses. Their preferred deal structure involves an initial investment of $3 to $7 million, with additional follow-on capital available, and they have the capacity to lead larger deals through syndication. Priveq primarily focuses on companies in Canada and the United States, specifically within a five-hour travel radius of Toronto, Canada, and also invests in companies within the Nordic region, including Sweden and Norway. As of May 2026, Priveq has approximately $1.2 billion USD in assets under management. PRIVEQ G.P. IV LIMITED specifically has less than $150 million in total assets under management and operates two private funds.

Related lists

• Series C+ Healthcare investors